Medically reviewed by Mary Choy, PharmD Key Takeaways Mounjaro often leads to greater reductions in hemoglobin A1C and weight compared to similar medications.Trulicity can help reduce major ...

Eli Lilly and Co. (NYSE:LLY) released topline results from SURPASS-CVOT, a head-to-head Phase 3 cardiovascular outcomes trial comparing Mounjaro (tirzepatide), a GIP/GLP-1 dual receptor agonist, to ...

The selected medications treat a range of conditions, including cancer, psoriatic arthritis, and human immunodeficiency virus type 1 infection.

The popular type 2 diabetes drug dulaglutide (Trulicity), botulinum toxin (Botox), and drugs to treat psoriatic arthritis, prostate cancer, and breast cancer are among the 15 drugs that the Centers ...

Eli Lilly said its blockbuster diabetes drug Mounjaro showed similar heart health benefits as the company's older diabetes treatment, Trulicity, in a late-stage trial directly comparing the two ...

The Centers for Medicare and Medicaid Services (CMS) have announced the next 15 drugs whose prices will be negotiated as part of the third round of Medicare negotiations. This latest round of ...

Mounjaro met the primary objective of non-inferiority vs. Trulicity with an 8% lower rate of MACE-3 events, while delivering greater reductions in A1C and weight In the trial, Mounjaro was associated ...